8. Hypertensive disorders in pregnancy. Eclampsia. HELLP-syndrome Flashcards
what is the definition of chronic HTN (preexisting)
> 140/90 mmHg
Sustained; present before 20 w’
gestation, persists > 12 w’ after delivery
definition of gestational HTN
> 140/90 mmHg
Sustained; present after 20 w’ gestation
resolves within < 12 w’ from delivery
management of chronic and gestational HTN
- Antihypertensive during pregnancy:
- Hydralazine (short-term)
- Labetalol (short-term)
- α-methyldopa (long-term)
- Nifedipine (long-term) - Frequent follow-up:
- Fetal surveillance (NST, US)
- Renal function and urinalysis
- BP monitoring - Deliver at 37-39 w’ gestation
- Low-dose aspirin (81 mg daily) may
reduce the risk of preeclampsia in
high-risk patients
definition of preeclampsia
> 140/90 mmHg
Sustained; diagnosed after 20 w’ gestation
and Proteinuria > 0.3 g/L in 24-h’
management of preeclampsia
> 37 w’ gestation → delivery
< 37 w’ gestation → close F/U, screen for alarm symptoms
preeclampsia with severe features
> 140/90 mmHg
Sustained; diagnosed after 20 w’ gestation
and Proteinuria > 5 g/L in 24-h’
*BP > 160/110 mmHg
*PLT count < 100,000/μL
*Serum Cr > 1.1 mg/dL or doubling of baseline concentration in the absence of renal disease
*↑ ALT or AST (> 2x normal)
*Pulmonary edema
*New-onset headache (refractory to standard
analgesics)
*Visual symptoms
management of preeclampsia with severe features
- Magnesium sulfate (continue for 24 h’ after delivery – prophylaxis)
- Delivery (urgently → induction or C-section)
- BP control (IV hydralazine)
Eclampsia management
- Magnesium sulfate (abort seizure)
- stabilization (ABC)
- Delivery (emergent C-section)
what occurs in eclampsia?
> 140/90 mmHg
Imposed on preeclampsia or gestational HTN
*any type of urinalysis- proteinuria or no
*Seizures (cannot be attributed to any other cause)
what is Superimposed preeclampsia ?
preeclampsia in patients with preexisting chronic HTN; seen in up to 25% of patients with chronic HTN.
what does diagnosis of HTN require ?
recording of elevated blood pressure (> 140/90 mmHg) on at least 2 occasions, at least 4 hours apart.
Pathogenesis of preeclampsia/eclampsia
- Inadequate placental implantation (cytotrophoblastic invasion of the spiral uterine arteries) → wide-spread vascular endothelial dysfunction and vasospasm → ischemia → release of toxins into the systemic circulation that further exacerbate endothelial dysfunction → systemic signs and symptoms.
- Reduced placental synthesis of vasodilators prostaglandins.
3.Increased placental synthesis of agents antagonizing VEGF and TGF-β.
risk factors of preeclampsia/eclampsia
- Nulliparity
- Maternal age (> 35 years or < 15 years)
- Multiple gestation
- History of renal disease or chronic HTN
- History of preeclampsia/eclampsia
- Diabetes mellitus
- Obesity
- Antiphospholipid syndrome
complications of preeclampsia
Placental abruption
Coagulopathy
AKI
HELLP syndrome
Eclampsia
complication of eclampsia
- Stroke (hemorrhagic or thrombotic)
- ARDS
- AKI
- Hemorrhagic shock